Company Analysis Eurofins Scientific SE
1. Summary
Advantages
- Dividends (2.24%) are higher than the sector average (1.76%).
- The stock's return over the last year (-20.7%) is higher than the sector average (-34.04%).
- Current debt level 32.04% is below 100% and has decreased over 5 years from 45.34%.
Disadvantages
- Price (61.69 $) is higher than fair price (22.23 $)
- The company's current efficiency (ROE=8.41%) is lower than the sector average (ROE=13.19%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Eurofins Scientific SE | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 4.6% | -1.2% |
| 90 days | -19.2% | -37.6% | 5.3% |
| 1 year | -20.7% | -34% | 22.8% |
ERFSF vs Sector: Eurofins Scientific SE has outperformed the "Healthcare" sector by 13.34% over the past year.
ERFSF vs Market: Eurofins Scientific SE has significantly underperformed the market by -43.51% over the past year.
Stable price: ERFSF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ERFSF with weekly volatility of -0.398% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (61.69 $) is higher than the fair price (22.23 $).
Price is higher than fair: The current price (61.69 $) is 64% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (38.13) is higher than that of the sector as a whole (31.48).
P/E vs Market: The company's P/E (38.13) is lower than that of the market as a whole (46.91).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.16) is lower than that of the sector as a whole (3.36).
P/BV vs Market: The company's P/BV (3.16) is higher than that of the market as a whole (-8.98).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.82) is lower than that of the sector as a whole (3.24).
P/S vs Market: The company's P/S indicator (1.82) is lower than that of the market as a whole (4.88).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (12.89) is higher than that of the sector as a whole (9.95).
EV/Ebitda vs Market: The company's EV/Ebitda (12.89) is lower than that of the market as a whole (25.28).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -5.81% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-5.81%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-52.93%).
5.4. ROE
ROE vs Sector: The company's ROE (8.41%) is lower than that of the sector as a whole (13.19%).
ROE vs Market: The company's ROE (8.41%) is higher than that of the market as a whole (-8.22%).
5.5. ROA
ROA vs Sector: The company's ROA (3.15%) is lower than that of the sector as a whole (6.14%).
ROA vs Market: The company's ROA (3.15%) is lower than that of the market as a whole (4.85%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.03%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 2.24% is higher than the average for the sector '1.76%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.24% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 2.24% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (61.86%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
